Morgan Stanley’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2M Sell
520,213
-24,806
-5% -$1.41M ﹤0.01% 2449
2025
Q4
$22.6M Sell
545,019
-97,395
-15% -$4.03M ﹤0.01% 2821
2025
Q3
$25.9M Sell
642,414
-1,225,734
-66% -$35.6M ﹤0.01% 2643
2025
Q2
$48.6M Buy
1,868,148
+923,067
+98% +$22.2M ﹤0.01% 1961
2025
Q1
$23.1M Buy
945,081
+219,854
+30% +$6.18M ﹤0.01% 2547
2024
Q4
$20.8M Buy
725,227
+490,356
+209% +$16.8M ﹤0.01% 2714
2024
Q3
$8.86M Buy
234,871
+140,162
+148% +$4.91M ﹤0.01% 3526
2024
Q2
$2.99M Buy
94,709
+20,985
+28% +$727K ﹤0.01% 4294
2024
Q1
$3.24M Buy
+73,724
New +$3.01M ﹤0.01% 4251

Other funds holding CGON